Evidence map›Paper›PMID 29473878›Full record

ReviewInternational journal of molecular sciences2018

Alternative mRNA Splicing in the Pathogenesis of Obesity.

Chi-Ming Wong, Lu Xu, Mabel Yin-Chun Yau

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. mRNA Isoforms and Variants in Health and Disease.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Role of Recognition MicroRNAs inPathogens (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Alternative RNA Splicing in Fatty Liver Disease.Frontiers in endocrinology · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Regulation of alternative splicing in obesity-induced hypertension.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Chi-Ming WongDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. chi-ming.cm.wong@polyu.edu.hk.
Lu XuThe State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. irisxu@hku.hk.
Mabel Yin-Chun YauSchool of Medical and Health Sciences, Tung Wah College, Hong Kong, China. mabelyau@twc.edu.hk.
University of Hong Kong · HKTung Wah College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative mRNA splicing is an important mechanism in expansion of proteome diversity by production of multiple protein isoforms. However, emerging evidence indicates that only a limited number of annotated protein isoforms by alternative splicing are detected, and the coding sequence of alternative splice variants usually is only slightly different from that of the canonical sequence. Nevertheless, mis-splicing is associated with a large array of human diseases. Previous reviews mainly focused on hereditary and somatic mutations in cis-acting RNA sequence elements and trans-acting splicing factors. The importance of environmental perturbations contributed to mis-splicing is not assessed. As significant changes in exon skipping and splicing factors expression levels are observed with diet-induced obesity, this review focuses on several well-known alternatively spliced metabolic factors and discusses recent advances in the regulation of the expressions of splice variants under the pathophysiological conditions of obesity. The potential of targeting the alternative mRNA mis-splicing for obesity-associated diseases therapies will also be discussed.

Indexed as

Alternative SplicingAnimalsHumansModels, BiologicalMolecular Targeted TherapyObesityRNA, MessengerRNA, Messengeralternative mRNA splicingFox-1 Homolog 2insulin receptorleptin receptorlipin-1LMNANOVA splicing factorsnuclear receptor corepressorobesity-related diseasesRNA binding proteinsplice variantssplicing factors

Identifiers

PMID29473878
PMCPMC5855854
OpenAlexW2790579696

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.